Nomura Research Institute Ltd. (NRILY) Stock Price & How to Invest

Nomura Research Institute, Ltd. (NRI) builds, runs and consults on information systems for large Japanese companies and government bodies. It reports four segments. Financial IT Solutions is the largest, with ~¥405 billion of revenue in the fiscal year ended March 31, 2026 (FY3/2026), serving securities firms, insurers and banks with custom systems and with shared platforms that many clients run on at once, such as THE STAR for brokerage back offices, T-STAR for asset managers and BESTWAY for bank fund sales. Industrial IT Solutions (~¥280 billion) serves distribution, manufacturing, services and the public sector. IT Platform Services (~¥222 billion, much of it internal to the other segments) runs data centers, cloud and security, and Consulting (~¥69 billion) is the think-tank and strategy arm. Group revenue was ¥814.7 billion, up 6.5%, and overseas revenue was only ~13% of the total.

The company traces back to 1965, when the original Nomura Research Institute was founded as what NRI calls Japan's first full-scale private think tank, and to Nomura Computer Systems, set up in 1966. The two merged in 1988 to form today's NRI, which listed on the Tokyo Stock Exchange in 2001. Over the past decade it bought abroad to build a second leg outside Japan, mainly in Australia (NRI Australia, including the Planit testing business and the brokerage-services firm AUSIEX) and in North America (Core BTS, now rebranded NRI North America). Those deals are the source of FY3/2026's big write-down.

Nomura Holdings remains the largest shareholder with ~20.1% of shares outside treasury as of March 2026, followed by Japanese trust banks, Nippon Life (~4.3%) and the NRI employee stock ownership association (~4.1%). Nomura Properties holds another ~2.8%. Kaga Yanagisawa is President and CEO. The group had 16,894 employees as of March 31, 2026, about 7,982 of them at the parent company. NRI's fiscal year ends March 31, and it pays dividends twice a year.

The investment picture splits into two stories. Reported operating profit fell 56.8% to ¥58.3 billion in FY3/2026 because NRI booked ~¥97 billion of impairments on NRI Australia and Core BTS, which pushed profit attributable to owners down to ¥15.3 billion. Strip out those one-offs and business profit rose 16.3% to ¥156.7 billion, a 19.2% margin, and the first quarter of FY3/2027 showed operating profit up 12.0% with a 19.8% margin. Management guides to ¥175 billion of operating profit this fiscal year and targets ¥200 billion by FY3/2029, and it spent ~¥70 billion on buybacks between May and June 2026. NRILY itself is an unsponsored Citibank ADR traded over the counter, so holders get NRI's yen economics translated into dollars.

The most visible risk is that NRI's acquisitions abroad keep disappointing: the ~¥97 billion of FY3/2026 impairments at NRI Australia and Core BTS wiped out most of that year's reported profit, and the new targets of ~¥120 billion of overseas revenue at a ~5% margin still have to be delivered by businesses that shrank last year. At home, revenue is concentrated in Japanese financial institutions, so a slowdown in IT spending by brokers, banks or insurers, or consolidation among them, would hit the largest and most profitable segment; the company's own outlook warns that spending may be held back if client earnings weaken. Generative AI cuts both ways for a firm that bills for system development: NRI reports 10x to 30x productivity gains on some projects, which could lift margins but could also push clients to expect lower prices or to do more in-house. Competition for scarce engineers in Japan can also squeeze project margins. Public-sector work is lumpy, as the June 2026 quarter showed when slow public orders cut Consulting profit by 8.7%. Nomura Holdings' ~20% stake gives it influence and also means any future sell-down could weigh on the shares. For NRILY holders specifically, returns are exposed to the yen-dollar rate, the ADR is an unsponsored over-the-counter program with thinner trading and wider spreads than the Tokyo listing, and Japanese tax is withheld from dividends before they reach US holders. Finally, the ¥175 billion operating-profit forecast for FY3/2027 assumes growth continues while NRI steps up spending on AI, security and R&D (forecast at ¥8 billion, up 47.8%).

We give no verdict on Nomura Research Institute Ltd.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Financial IT and shared platforms. Financial IT Solutions is where most of NRI's profit sits.

The case against. The most visible risk is that NRI's acquisitions abroad keep disappointing: the ~¥97 billion of FY3/2026 impairments at NRI Australia and Core BTS wiped out most of that year's reported profit, and the new targets of ~¥120 billion of overseas revenue at a ~5% margin still have to be delivered by businesses that shrank last year.

Read the full bull and bear case on NRILY, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Nomura Research Institute Ltd.'s investor relations page or your broker.

• Revenue (FY3/2026): ~¥814.7B (+6.5%)
• Revenue (TTM to June 2026): ~¥829B
• Business profit (FY3/2026, excl. impairments): ~¥156.7B (19.2% margin)
• Operating profit guidance (FY3/2027): ~¥175B on ~¥850B revenue
• Dividend per share (FY3/2027 forecast): ¥84 (¥42 semiannual)
• Net debt-to-equity (March 2026): ~0.05x

The reported numbers for FY3/2026 look worse than the business underneath them. Operating profit of ¥58.3 billion and earnings per share of ¥26.62 include ~¥97 billion of non-cash impairments, while business profit, which excludes those one-offs, grew 16.3% and operating cash flow rose 13.4% to ¥147.6 billion. Guidance for FY3/2027 implies a return to ~¥175 billion of operating profit and basic EPS of ~¥207, close to the run rate the June 2026 quarter suggested (EPS of ¥51.42 for three months). A shrinking share count from buybacks and cancellations adds to per-share growth. All figures are in yen; NRILY's dollar price moves with both the Tokyo share price and the exchange rate.

Other names that sit close to NRILY: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get NRILY exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so NRILY sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where NRILY fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

NRILY gives US investors a yen-denominated stake in a dominant Japanese financial-IT franchise that is shrinking its overseas ambitions and returning cash, with the open question being whether AI raises or erodes the value of the system-building work it is paid for.

Whether NRILY is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is NRILY a buy or a sell?, and where the stock could go from here in the NRILY stock forecast.

For income investors, whether NRILY pays a dividend and how the payout looks is covered in does NRILY pay a dividend? And to weigh NRILY against a peer, read the full side-by-side comparisons: NRILY vs ACN and NRILY vs IBM.